Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.6800 (7.92%) ($6.1000 - $6.7000) on Mon. Aug. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.52% (three month average) | RSI | 33 | Latest Price | $6.6800(7.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -13% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TLT(26%) IGOV(25%) VCIT(20%) TIP(16%) LQD(6%) | Factors Impacting CAPR price | CAPR will decline at least -4.26% in a week (0% probabilities). URA(-36%) XLB(-33%) PAVE(-27%) XOP(-25%) OIH(-25%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.26% (StdDev 8.52%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.31 | 5 Day Moving Average | $6.34(5.36%) | 10 Day Moving Average | $6.81(-1.91%) | 20 Day Moving Average | $7.31(-8.62%) | To recent high | -31.9% | To recent low | 33.3% | Market Cap | $132m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |